Nectar Lifesciences Files Certificate Under SEBI Regulations for Q3FY26

Nectar Lifesciences Limited has submitted a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate pertain...

Nectar Lifesciences Limited has submitted a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025. The certificate was received from Kfin Technologies Limited, the Company's Registrar and Share Transfer Agent. It confirms that any securities received from depository participants for dematerialization during the quarter were processed and confirmed with the depositories. Accepted security certificates were duly cancelled, and the depositories were substituted as the registered owners within the prescribed timelines. The company has requested that this information be taken on record. The submission was made to the National Stock Exchange of India Limited and BSE Limited on January 3, 2026.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Nectar Lifesciences Limited in the news today?

Nectar Lifesciences Limited (NECLIFE) is in the news due to the announcement is a routine compliance filing regarding the processing of dematerialized securities and does not contain any new financial information or significant business developments.

SEBI Compliance FilingsShareholding Pattern
Nectar Lifesciences LimitedNECLIFEhttps://prysm.fi/v2/analyze/NECLIFE

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Nectar Lifesciences Files Certificate Under SEBI Regulations for Q3FY26

January 3, 2026, 04:19 AM

AI Sentiment Analysis

Top Queries to Ask About Nectar Lifesciences Limited

More Details on This News

Nectar Lifesciences Limited has submitted a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025.

The certificate was received from Kfin Technologies Limited, the Company's Registrar and Share Transfer Agent. It confirms that any securities received from depository participants for dematerialization during the quarter were processed and confirmed with the depositories. Accepted security certificates were duly cancelled, and the depositories were substituted as the registered owners within the prescribed timelines.

The company has requested that this information be taken on record. The submission was made to the National Stock Exchange of India Limited and BSE Limited on January 3, 2026.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Nectar Lifesciences Limited

Discover more trending news on Prysm

View All